Skip to main content
Fig. 6 | World Journal of Surgical Oncology

Fig. 6

From: A new marker constructed from immune-related lncRNA pairs can be used to predict clinical treatment effects and prognosis: in-depth exploration of underlying mechanisms in HNSCC

Fig. 6

Mutation analysis. A, B Waterfall charts reflect the gene mutations of patients in the high-risk and low-risk groups. C The contrast of TMB content between the high-risk group and low-risk group. D The KM survival correlation analysis shows the difference between the high TMB and the low TMB groups. E The display of the risk score differences between the TP53 mutant group and TP53 wild group. F The KM survival analysis reveals the difference in survival probability between the TP53 mutation group and TP53 wild groups. G The fraction differences between the TP53 mutant group and TP53 wild group in 22 immune cells. H The difference in the expression level of PDL1 between the high-risk and low-risk groups

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us